Prime Care Portfolio (PCP) [Anti-Diabetics (AD), Cardiology (CVS), Gastrointestinal (GIT)]

Prime Care Portfolio (PCP) [Anti-Diabetics (AD), Cardiology (CVS), Gastrointestinal (GIT)]

Products and Business Services
Prime Care Portfolio (PCP) [Anti-Diabetics (AD), Cardiology (CVS), Gastrointestinal (GIT)]
Prime Care Portfolio (PCP) [Anti-Diabetics (AD), Cardiology (CVS), Gastrointestinal (GIT)]
Prime Care Portfolio (PCP) [Anti-Diabetics (AD), Cardiology (CVS), Gastrointestinal (GIT)]

Information

6- Anti-Diabetics (AD): “Empowering Control, Embracing Health” I. Dapxiga 5mg & 10mg • API: Dapagliflozin. II. Liptyn 5mg • API: Linagliptin. III. Geuvid 50mg • API: Vildagliptin. IV. Meliglptin 50mg & 100mg • API: Sitagliptin V. Meligamet 50 mg / 1000 mg & 50 mg / 850 mg • API: Sitagliptin + Metformin HCl VI. Diafor 500mg, 750mg & 1000mg • API: Metformin HCl 7- Cardiology (CVS): “Stronger Hearts, Healthier Lives” I. Olmy 20mg & 40mg • API: Olmesartan medoxomil. II. Olmevasc 5/20mg, 5/40mg, 10/20mg & 10/40mg • API: Amlodipine + Olmesartan medoxomil. III. Olmazide 20/12.5mg, 40/12.5mg & 40/25mg • API: Olmesartan medoxomil + Hydrochlorothiazide. IV. Aprolin 10mg, 25mg & 50mg • API: Hydralazine HCl. V. Lertiv 10mg & 20mg • API: Lercanidipine HCl. VI. Bivoneb 5mg • API: Nebivolol. VII. Rost 10mg, 20mg & 40mg • API: Rosuvastatin. VIII. Lipofirate 145mg • API: Fenofibrate. IX. Xcard 2.5mg & 5mg • Apixaban. X. Rivax 2.5mg, 10mg, 15mg & 20mg • API: Rivaroxaban. XI. Dabitran 75mg, 110mg & 150mg • Dabigatran etexilate. XII. Devasc 75mg • API: Clopidogrel. 8- Gastrointestinal (GIT): “Trusted Relief, Lasting Wellness” I. Esopole 20mg & 40mg • API: Esomeprazole Magnesium. II. Pantrox 20mg & 40mg • API: Pantoprazole III. Peploc 10mg, 20mg & 40mg • API: Famotidine IV. Eulax 17g • API: Polyethylene Glycol
Distribution Areas
Middle East Region (e.g. UAE)
Main Categories
Finished Dosage Forms
Amarox KSASaudi Amarox is a rapidly growing pharmaceutical company that has established itself as a trusted name in the global generics market. Its headquarters are in Riyadh, the capital of the Kingdom of Saudi Arabia (KSA). The company aims to manufacture and supply high-quality generic medicine to meet the diverse healthcare needs of the Middle East region. Saudi Amarox's mission is to manufacture and access high-quality medicines through a robust distribution network and establish the Acceptance of the entire population in the region. This commitment to quality is a cornerstone of Saudi Amarox's business strategy, as the company recognizes that access to affordable and trustable medicines is crucial for improving the health and well-being of people in the Middle East. Beyond quality, Saudi Amarox is also deeply investing to enhance the accessibility of its products throughout the region. The company understands the unique healthcare challenges faced by some Middle Eastern countries, such as limited access to essential medications and the need for affordable treatment options. By strategically positioning itself as a leading supplier of best-in-class generics, Saudi Amarox aims to bridge this gap and participate in improving the healthcare landscape in the region.

Log in

See all the content and easy-to-use features by logging in or registering!